ClinicalTrials.Veeva

Menu

Positron Emission Tomography - Computed Tomography (PET-CT) Scan as a Diagnostic Method in Unknown Primary Tumors

Rigshospitalet logo

Rigshospitalet

Status

Completed

Conditions

Unknown Primary Tumor

Treatments

Procedure: PET-CT

Study type

Observational

Funder types

Other

Identifiers

NCT00269373
01 283694

Details and patient eligibility

About

Is PET-CT scan better than PET or CT alone in diagnosing primary tumours in patients with unknown primary tumors? Can information obtained with PET-CT replace other clinical and radiological investigations? Is PET/CT cost-effective?

Full description

Patients who fulfill the international definition of unknown primary tumors can be included, except:

  • Young men (<55 years) with growing mid-line tumors where a germ cell tumor could be expected will not be included.
  • Patients with lymph-node metastases with squamous cell carcinoma in the head and neck region will not be included.
  • Women with adenocarcinoma in lymph nodes in the axilla will not be included.

Enrollment

136 patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Unknown primary tumors

Exclusion criteria

  • Young men (<55 years) with growing mid-line tumors where a germ cell tumor could be expected will not be included.
  • Patients with lymph-node metastases with squamous cell carcinoma in the head and neck region will not be included
  • Women with adenocarcinoma in lymph nodes in the axilla will not be included

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems